Lipid Nanoparticles for the Posterior Eye Segment

被引:53
作者
Bonilla, Lorena [1 ,2 ]
Espina, Marta [1 ,2 ]
Severino, Patricia [3 ]
Cano, Amanda [1 ,2 ,4 ]
Ettcheto, Miren [4 ,5 ]
Camins, Antoni [4 ,5 ]
Garcia, Maria Luisa [1 ,2 ,5 ]
Souto, Eliana B. [6 ]
Sanchez-Lopez, Elena [1 ,2 ,4 ]
机构
[1] Univ Barcelona, Fac Pharm, Dept Pharm Pharmaceut Technol & Phys Chem, Barcelona 08028, Spain
[2] Univ Barcelona, Inst Nanosci & Nanotechnol IN2UB, Barcelona 08028, Spain
[3] Univ Tiradentes UNIT, Ind Biotechnol Program, Ave Murilo Dantas 300, BR-49032490 Aracaju, Brazil
[4] Univ Barcelona, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona 08028, Spain
[5] Univ Barcelona, Fac Pharm & Food Sci, Dept Pharmacol Toxicol & Therapeut Chem, Barcelona 08028, Spain
[6] Univ Minho, CEB Ctr Biol Engn, Campus Gualtar, P-4710057 Braga, Portugal
关键词
ocular drug delivery; ocular barriers; lipid nanoparticles; posterior segment; drug transport; NLC; SLN; DRUG-DELIVERY SYSTEMS; OCULAR DELIVERY; IN-VITRO; DIABETIC-RETINOPATHY; OPHTHALMIC DELIVERY; SUSTAINED-RELEASE; MITOMYCIN-C; CARRIERS; CHITOSAN; OPTIMIZATION;
D O I
10.3390/pharmaceutics14010090
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review highlights the application of lipid nanoparticles (Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, or Lipid Drug Conjugates) as effective drug carriers for pathologies affecting the posterior ocular segment. Eye anatomy and the most relevant diseases affecting the posterior segment will be summarized. Moreover, preparation methods and different types and subtypes of lipid nanoparticles will also be reviewed. Lipid nanoparticles used as carriers to deliver drugs to the posterior eye segment as well as their administration routes, pharmaceutical forms and ocular distribution will be discussed emphasizing the different targeting strategies most recently employed for ocular drug delivery.
引用
收藏
页数:30
相关论文
共 159 条
[81]   Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery [J].
Mohanty, Biswaranjan ;
Majumdar, Dipak K. ;
Mishra, Sagar K. ;
Panda, Amulya K. ;
Patnaik, Soma .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2015, 20 (04) :458-464
[82]   Penetration Enhancers in Ocular Drug Delivery [J].
Moiseev, Roman, V ;
Morrison, Peter W. J. ;
Steele, Fraser ;
Khutoryanskiy, Vitaliy V. .
PHARMACEUTICS, 2019, 11 (07)
[83]   Retinal and choroidal vascular occlusion after posterior sub-tenon triamcinolone injection [J].
Moshfeghi, DM ;
Lowder, CY ;
Roth, DB ;
Kaiser, PK .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 134 (01) :132-134
[84]  
Muller Rainer H, 2011, Curr Drug Discov Technol, V8, P207
[85]  
Müller RH, 2002, INT J PHARMACEUT, V242, P121, DOI 10.1016/s0378-5173(02)00180-1
[86]   Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations [J].
Müller, RH ;
Radtke, M ;
Wissing, SA .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 :S131-S155
[87]   Solid lipid nanoparticles (SLN) for controlled drug delivery -: a review of the state of the art [J].
Müller, RH ;
Mäder, K ;
Gohla, S .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) :161-177
[88]   Biocompatibility of engineered nanoparticles for drug delivery [J].
Naahidi, Sheva ;
Jafari, Mousa ;
Edalat, Faramarz ;
Raymond, Kevin ;
Khademhosseini, Ali ;
Chen, P. .
JOURNAL OF CONTROLLED RELEASE, 2013, 166 (02) :182-194
[89]   Clarithromycin Solid Lipid Nanoparticles for Topical Ocular Therapy: Optimization, Evaluation, and In Vivo Studies [J].
Nair, Anroop B. ;
Shah, Jigar ;
Al-Dhubiab, Bandar E. ;
Jacob, Shery ;
Patel, Snehal S. ;
Venugopala, Katharigatta N. ;
Morsy, Mohamed A. ;
Gupta, Sumeet ;
Attimarad, Mahesh ;
Sreeharsha, Nagaraja ;
Shinu, Pottathil .
PHARMACEUTICS, 2021, 13 (04)
[90]   Nanocarrier for Poorly Water-Soluble Anticancer Drugs-Barriers of Translation and Solutions [J].
Narvekar, Mayuri ;
Xue, Hui Yi ;
Eoh, June Young ;
Wong, Ho Lun .
AAPS PHARMSCITECH, 2014, 15 (04) :822-833